SCHEMBL7076418

SCHEMBL7076418

Cc1ccccc1Nc1ccc(/C(=N/O)c2cccn2C)c(Cl)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 13/20 0.53
MAPK13 O15264 12/20 0.53
MAPK12 P53778 12/20 0.53
MAPK11 Q15759 12/20 0.53
SMN1; SMN2 Q16637 4/20 0.40
HSD17B10 Q99714 1/20 0.40
GRM1 Q13255 1/20 0.37
NPC1 O15118 2/20 0.36
RAB9A P51151 2/20 0.36
GAA P10253 1/20 0.36
MAPK1 P28482 1/20 0.36
AVPR2 P30518 1/20 0.35
OXTR P30559 1/20 0.35
AVPR1A P37288 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7076419 1.00 MAPK14 (0.53) MAPK14MAPK13MAPK12MAPK11SMN1; SMN2
SCHEMBL7082298 0.88 MAPK14 (0.51) MAPK14MAPK13MAPK12MAPK11SMN1; SMN2
SCHEMBL7082301 0.88 MAPK14 (0.51) MAPK14MAPK13MAPK12MAPK11SMN1; SMN2
SCHEMBL7079524 0.84 MAPK14 (0.55) MAPK14MAPK13MAPK12MAPK11SMN1; SMN2
SCHEMBL7076455 0.84 MAPK14 (0.68) MAPK14MAPK13MAPK12MAPK11SMN1; SMN2
SCHEMBL7075172 0.83 MAPK13 (0.56) MAPK14MAPK13MAPK12MAPK11SMN1; SMN2
SCHEMBL7075166 0.83 MAPK13 (0.56) MAPK14MAPK13MAPK12MAPK11SMN1; SMN2
SCHEMBL7083146 0.83 MAPK14 (0.51) MAPK14MAPK13MAPK12MAPK11GRM1
SCHEMBL7083149 0.83 MAPK14 (0.51) MAPK14MAPK13MAPK12MAPK11GRM1
SCHEMBL5173645 0.82 MAPK14 (0.68) MAPK14MAPK13MAPK12MAPK11AVPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US claimed
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073832-A1 Novel aminophenyl ketone derivatives MAPKAPK2, MAP3K2, MAP3K1 MAPK14 28/4885MAPK13 33/4885MAPK12 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.